These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 35945116)

  • 1. Assessment of gastrointestinal function and its' effect on bone mineral density and body composition in hypermobility spectrum disorder and hypermobile Ehlers-Danlos syndrome.
    DiFrancisco-Donoghue J; Southard V; Margulies M; Jung MK; Allera A; Riley B
    J Clin Densitom; 2022; 25(4):536-543. PubMed ID: 35945116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rome IV Functional Gastrointestinal Disorders and Health Impairment in Subjects With Hypermobility Spectrum Disorders or Hypermobile Ehlers-Danlos Syndrome.
    Lam CY; Palsson OS; Whitehead WE; Sperber AD; Tornblom H; Simren M; Aziz I
    Clin Gastroenterol Hepatol; 2021 Feb; 19(2):277-287.e3. PubMed ID: 32109633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone parameters in hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorder: A comparative cross-sectional study.
    Coussens M; Banica T; Lapauw B; De Wandele I; Rombaut L; Malfait F; Calders P
    Bone; 2023 Jan; 166():116583. PubMed ID: 36243401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher fracture prevalence and smaller bone size in patients with hEDS/HSD-a prospective cohort study.
    Banica T; Coussens M; Verroken C; Calders P; De Wandele I; Malfait F; Zmierczak HG; Goemaere S; Lapauw B; Rombaut L
    Osteoporos Int; 2020 May; 31(5):849-856. PubMed ID: 31873762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics of patients with hypermobile type Ehlers-Danlos syndrome (hEDS) and generalized hypermobility spectrum disorders (G-HSD): an online survey.
    Teran-Wodzinski P; Kumar A
    Rheumatol Int; 2023 Oct; 43(10):1935-1945. PubMed ID: 37378685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Healthcare experiences among adults with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorder in the United States.
    Estrella E; Frazier PA
    Disabil Rehabil; 2024 Feb; 46(4):731-740. PubMed ID: 36772820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscle Strength, Muscle Mass and Physical Impairment in Women with hypermobile Ehlers-Danlos syndrome and Hypermobility Spectrum Disorder.
    Coussens M; Lapauw B; Banica T; De Wandele I; Pacey V; Rombaut L; Malfait F; Calders P
    J Musculoskelet Neuronal Interact; 2022 Mar; 22(1):5-14. PubMed ID: 35234154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of pain with gait spatiotemporal parameters in children with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorder.
    Jeong HJ; Engel JM; Muriello M; Basel D; Slavens BA
    Gait Posture; 2024 Mar; 109():271-276. PubMed ID: 38368648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developing a self-management intervention to manage hypermobility spectrum disorders (HSD) and hypermobile Ehlers-Danlos syndrome (hEDS): an analysis informed by behaviour change theory.
    Bennett SE; Walsh N; Moss T; Palmer S
    Disabil Rehabil; 2022 Sep; 44(18):5231-5240. PubMed ID: 34101520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional gastrointestinal disorders are increased in joint hypermobility-related disorders with concomitant postural orthostatic tachycardia syndrome.
    Tai FWD; Palsson OS; Lam CY; Whitehead WE; Sperber AD; Tornblom H; Simren M; Aziz I
    Neurogastroenterol Motil; 2020 Dec; 32(12):e13975. PubMed ID: 32803794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laryngological Complaint Prevalence in Hypermobile Ehlers-Danlos or Hypermobility Spectrum Disorders.
    Menton SM; Fairweather D; Bruno KA; Thompson CC; Candelo E; Darakjian AA; Gehin JM; Jain A; Kotha A; Whelan ER; Li Z; Knight DRT; Rutt AL
    Laryngoscope; 2024 Feb; 134(2):773-778. PubMed ID: 37597175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does Muscle Strength Change Over Time in Patients With Hypermobile Ehlers-Danlos Syndrome/Hypermobility Spectrum Disorder? An Eight-Year Follow-Up Study.
    Coussens M; Calders P; Lapauw B; Celie B; Banica T; De Wandele I; Pacey V; Malfait F; Rombaut L
    Arthritis Care Res (Hoboken); 2021 Jul; 73(7):1041-1048. PubMed ID: 32293111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fear avoidance, fear of falling, and pain disability in hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.
    Chuchin JD; Ornstein TJ
    Disabil Rehabil; 2024 Sep; 46(18):4234-4245. PubMed ID: 37843031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional neurological signs in hypermobile Ehlers-Danlos syndrome and hypermobile spectrum disorders with suspected neuropathic pain.
    Fernandez A; Jaquet M; Aubry-Rozier B; Suter M; Aybek S; Berna C
    Brain Behav; 2024 Feb; 14(2):e3441. PubMed ID: 38409931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anorectal manometry for the diagnosis of pelvic floor disorders in patients with hypermobility spectrum disorders and hypermobile Ehlers-Danlos syndrome.
    Zhou W; Zikos TA; Halawi H; Sheth VR; Gurland B; Nguyen LA; Neshatian L
    BMC Gastroenterol; 2022 Dec; 22(1):538. PubMed ID: 36564719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are patients with hypermobile Ehlers-Danlos syndrome or hypermobility spectrum disorder so different?
    Aubry-Rozier B; Schwitzguebel A; Valerio F; Tanniger J; Paquier C; Berna C; Hügle T; Benaim C
    Rheumatol Int; 2021 Oct; 41(10):1785-1794. PubMed ID: 34398260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding hypermobile Ehlers-Danlos syndrome and Hypermobility Spectrum Disorders in the context of childbearing: An international qualitative study.
    Pezaro DS; Pearce DG; Reinhold DE
    Midwifery; 2020 Sep; 88():102749. PubMed ID: 32535291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation and Management of Dyspnea in Hypermobile Ehlers-Danlos Syndrome and Generalized Hypermobility Spectrum Disorder: Protocol for a Pilot and Feasibility Randomized Controlled Trial.
    Rozenberg D; Al Kaabi N; Camacho Perez E; Nourouzpour S; Lopez-Hernandez L; McGillis L; Goligher E; Reid WD; Chow CW; Ryan CM; Kumbhare D; Huszti E; Champagne K; Raj S; Mak S; Santa Mina D; Clarke H; Mittal N
    JMIR Res Protoc; 2023 Mar; 12():e44832. PubMed ID: 36939815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular manifestations of hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.
    Rashed ER; Ruiz Maya T; Black J; Fettig V; Kadian-Dodov D; Olin JW; Mehta L; Gelb BD; Kontorovich AR
    Vasc Med; 2022 Jun; 27(3):283-289. PubMed ID: 35000503
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.